On November 18, 2025, ToolGen, Inc. (“ToolGen”) filed a complaint (“Complaint”) in the District of Massachusetts alleging infringement of its ...

Chandigarh: The India International Science Festival (IISF) 2025 culminated Tuesday with sessions on celebrating Nari Shakti ...

Casgevy safely and effectively prevents vaso-occlusive crises in children ages 5 to 11 with severe sickle cell disease, trial ...

New gene-editing treatment promises to permanently lower cholesterol by 50%, but FDA safety rules require 15 years of ...

The global optic nerve atrophy treatment market size was valued at USD 2.53 billion in 2024 and is predicted to hit around ...

CRISPR Therapeutics recently drew attention as updates highlighted progress in its gene-editing pipeline, including early-stage studies of CTX310, an in vivo therapy designed to lower LDL cholesterol ...

On the 4th, the European Union (EU), once dubbed the “GMO, genetically modified organisms, regulatory stronghold” and known ...

Scientists have used a new type of gene therapy to cure leukaemia patients. The treatment, which uses edited immune cells ...

Kids and teenagers with spinal muscular atrophy had more mobility after receiving a single-dose gene replacement therapy, ...

The field of dermatology has witnessed remarkable progress in the prevention and treatment of skin diseases over the past ...

CAR7, has shown remarkable success in reversing an aggressive form of leukemia. This world-first treatment uses gene ...

Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.